Skip to main content
Article thumbnail
Location of Repository

Researching complementary and alternative treatments – the gatekeepers are not at home

By V Fønnebø, S Grimsgaard, Harald Walach, C Ritenbaugh, A Norheim, H MacPherson, G Lewith, L Launso, M Koithan, T Falkenberg, H Boon and M Aickin


Background: To explore the strengths and weaknesses of conventional biomedical research strategies and methods as applied to complementary and alternative medicine (CAM), and to suggest a new research framework for assessing these treatment modalities.\ud Discussion: There appears to be a gap between published studies showing little or no efficacy of CAM, and reports of substantial clinical benefit from patients and CAM practitioners. This "gap" might be partially due to the current focus on placebo-controlled randomized trials, which are appropriately designed to answer questions about the efficacy and safety of pharmaceutical agents.\ud In an attempt to fit this assessment strategy, complex CAM treatment approaches have been dissected into standardized and often simplified treatment methods, and outcomes have been limited. Unlike conventional medicine, CAM has no regulatory or financial gatekeeper controlling their\ud therapeutic "agents" before they are marketed. Treatments may thus be in widespread use before researchers know of their existence. In addition, the treatments are often provided as an integrated 'whole system' of care, without careful consideration of the safety issue. We propose a five-phase strategy for assessing CAM built on the acknowledgement of the inherent, unique aspects of CAM treatments and their regulatory status in most Western countries. These phases comprise:\ud 1. Context, paradigms, philosophical understanding and utilization\ud 2. Safety status\ud 3. Comparative effectiveness.\ud 4. Component efficacy\ud 5. Biological mechanisms.\ud Summary: Using the proposed strategy will generate evidence relevant to clinical practice, while\ud acknowledging the absence of regulatory and financial gatekeepers for CAM. It will also emphasize the important but subtle differences between CAM and conventional medical practic

Topics: R733
Publisher: BioMed Central
Year: 2007
OAI identifier:
Provided by: NECTAR

Suggested articles


  1. (2004). A preliminary audit investigating remedy reactions including adverse events in routine homeopathic practice. Homeopathy doi
  2. (2005). A: Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med doi
  3. (1998). A: Complementary medicine in cancer patients: Demand, patients' attitudes and psychological beliefs. Onkologie doi
  4. (2003). A: Whole systems research: a discipline for studying complementary and alternative medicine. Altern Ther Health Med doi
  5. (1996). Adverse effects of acupuncture: a study of the literature for the years 1981-1994. doi
  6. (2005). Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet doi
  7. Arnberg S: An exploratory study of reflexological treatment for headache. Altern Ther Health Med 1999, 5:57-65.Page 5 of 6 (page number not for citation purposes)
  8. (2000). Attitudes and Beliefs towards Disease and Treatment in Patients with Advanced Cancer Using Anthroposophical Medicine. Onkologie doi
  9. (1999). Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res doi
  10. (1991). BT: Use of non-orthodox and conventional health care in Great Britain. doi
  11. (2005). Building an evidence house: challenges and solutions to research in complementary and alternative medicine. Forsch Komplementarmed Klass Naturheilkd doi
  12. (2005). Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ doi
  13. (2002). Chodak GW: Attitudes and use of complementary medicine in men with prostate cancer. doi
  14. (2004). Criddle MW: Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making doi
  15. (1993). Delbanco TL: Unconventional Medicine in the United-States -Prevalence, Costs, and Patterns of Use. doi
  16. (2005). Effects of acupuncture on vasopressininduced emesis in conscious dogs.
  17. (2003). Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls. doi
  18. (2002). Evaluating complementary medicine: Lessons to be learned from evaluation research. doi
  19. (2000). Fonnebo V: A survey of acupuncture patients: results from a questionnaire among a random sample in the general population in Norway. Complement Ther Med doi
  20. (1995). Fonnebo V: Adverse effects of acupuncture. Lancet doi
  21. (1996). Fønnebø V: Acupuncture adverse effects are more than occasional case reports. Complement Ther Med doi
  22. (2005). General practitioners and classical homeopaths treatment models for asthma and allergy. Homeopathy doi
  23. (2005). Gluud LL: Evidence based diagnostics. BMJ doi
  24. (2005). Harm in homeopathy: aggravations, adverse drug events or medication errors? Homeopathy doi
  25. (2004). HR: Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ doi
  26. Investigating acupuncture using doi
  27. (2005). Investigating acupuncture using brain imaging techniques: the current state of play. Evid Based Complement Alternat Med doi
  28. (2005). JP: Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess doi
  29. (2004). Kiene H: Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS). doi
  30. (2003). Kisters K: [Use of complementary/alternative therapy methods by patients with breast cancer]. Forsch Komplementarmed Klass Naturheilkd doi
  31. (2005). Launso L: Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and physicians, respectively. Integr Cancer Ther doi
  32. (2005). Launsø L: Looking for new knowledge in the field of curing and healing. Focus Altern Complement Ther
  33. (2005). Ludtke R: Patients' assessments of the effectiveness of homeopathic care in Norway: a prospective observational multicentre outcome study. Homeopathy doi
  34. (2004). Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health
  35. (2003). Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Making doi
  36. (1998). Methodological and ethical issues in clinical trials of acupuncture. doi
  37. (2004). Patient reports of adverse events associated with acupuncture treatment: a prospective national survey. Qual Saf Health Care doi
  38. (1988). Placebos and common factors in two decades of psychotherapy research. Psychol Bull doi
  39. (2004). Pragmatic clinical trials. Complement Ther Med
  40. (2005). Rasmussen NK: Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care doi
  41. (1990). RC: Trends in alternative medicine use in the United States, doi
  42. (2005). SN: Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health doi
  43. (2000). The need for revision of medical research designs.
  44. The role of outcomes research in evaluating complementary and alternative medicine. doi
  45. (2005). The safety of Chinese herbal medicine: a pilot study for a national survey. doi
  46. (2001). The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists. BMJ doi
  47. (2005). Treish I, Zhang G: Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. doi
  48. (2001). Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med doi
  49. (2000). Use of alternative treatments in Denmark: patterns of use and patients' experience with treatment effects. Altern Ther Health Med
  50. (2002). WB: Balanced research strategies for complementary and alternative medicine. doi
  51. (2006). Whitlock E: Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA doi
  52. (1998). Why patients use alternative medicine: results of a national study. JAMA doi
  53. (2004). Zirkulär statt hierarchisch: Methodische Prinzipien bei der Evaluation der therapeutischen

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.